panel-3-strategic-protection-for-life-sciences
28 May 2026VideosAmericasPhil Hamzik, Wolf Greenfield | Adam Gastonguay, Regeneron | Paul Fleming, Seaport Therapeutics | Robin Weatherhead, Ventus Therapeutics | Erica LoRe, Invivyd

WATCH: Strategic protection for life sciences innovations in a changing landscape—trade secrets vs patents

Phil Hamzik, Shareholder at Wolf Greenfield, leads a panel discussion with Adam Gastonguay, Director and Patent Counsel at Regeneron; Paul Fleming, Senior Director of Intellectual Property at Seaport Therapeutics; Robin Weatherhead, Vice President of Intellectual Property and Legal at Ventus Therapeutics; and Erica LoRe, Senior Director and Intellectual Property Counsel at Invivyd.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
6 November 2026   Uncertainty over whether a patent can be challenged through inter partes review at the USPTO has only increased since the discretionary denial policy was introduced, so how should companies plan? Mauricio Uribe and Maria Anderson of Davis Wright Tremaine explain.
Americas
17 June 2026   A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned parallel proceedings before the Federal Circuit and PTAB.
Americas
15 June 2026   Unanimous jury finds willful infringement, with the possibility of a trebled award and a much larger feud still to come.